Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 5.
doi: 10.1111/jdv.19104. Online ahead of print.

VEXAS syndrome following COVID-19 mRNA vaccination

François Skowron  1 , Lucas Klepfisch  1 , Laurent Guillaume  2 , Janique Godeneche  3 , Anthony Facile  4 , Martin Gombert  5 , Suzann Pechuzal  6 , Jean-Luc Perrot  7
Affiliations

VEXAS syndrome following COVID-19 mRNA vaccination

François Skowron et al. J Eur Acad Dermatol Venereol. .
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W, et al. Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N Engl J Med. 2020;383(27):2628-38.
    1. Georgin-Lavialle S, Terrier B, Guedon AF, Heiblig M, Comont T, Lazaro E, et al. Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients. Br J Dermatol. 2022;186(3):564-74.
    1. Stubbins RJ, Cherniawsky H, Chen LYC, Nevill TJ. Innovations in genomics for undiagnosed diseases: vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome. CMAJ. 2022;194(14):E524-e7.
    1. Zakine E, Papageorgiou L, Bourguiba R, Mekinian A, Terrier B, Kosmider O, et al. Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: a multicenter retrospective study of 59 cases. J Am Acad Dermatol. 2023;88(4):917-20.
    1. Heiblig M, Ferrada MA, Koster MJ, Barba T, Gerfaud-Valentin M, Mekinian A, et al. Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study. Blood. 2022;140(8):927-31.

LinkOut - more resources